» Articles » PMID: 24364541

Metabolomic Characterization of Nipple Aspirate Fluid by (1)H NMR Spectroscopy and GC-MS

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2013 Dec 25
PMID 24364541
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Nipple aspirate fluid (NAF) is a noninvasively obtained biofluid from the duct openings of the breast. NAF components are constantly secreted, metabolized, and reabsorbed by the epithelial lining of the lactiferous ducts of the breast. NAF has been studied as a potential breast tissue surrogate for the discovery of novel breast cancer risk, early detection, and treatment response biomarkers. We report the first unsupervised metabolite characterization of nipple aspirate fluid using NMR and GC-MS using convenience samples previously collected from four premenopausal and four postmenopausal women. A total of 38 metabolites were identified using the two analytical techniques, including amino acids, organic acids, fatty acids, and carbohydrates. Analytical reproducibility of metabolites in NAF by GC-MS was high across different extraction and analysis days. Overall, 31 metabolites had a coefficient of variation below 20%. By GC-MS, there were eight metabolites unique to NAF, 19 unique to plasma, and 24 shared metabolites. Correlative analysis of shared metabolites between matched NAF and plasma samples from pre- and postmenopausal women shows almost no correlations, with the exception being lactic acid, which was significantly negatively correlated (R(2) = 0.57; P = 0.03). These results suggest that NAF is metabolically distinct from plasma and that the application of metabolomic strategies may be useful for future studies investigating breast cancer risk and intervention response biomarkers.

Citing Articles

MR spectroscopy in breast cancer metabolomics.

Sharma U, Jagannathan N Anal Sci Adv. 2024; 2(11-12):564-578.

PMID: 38715862 PMC: 10989566. DOI: 10.1002/ansa.202000160.


Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.

Sharma U, Jagannathan N Metabolites. 2022; 12(4).

PMID: 35448482 PMC: 9030399. DOI: 10.3390/metabo12040295.


Nipple Aspirate Fluid at a Glance.

Patuleia S, Suijkerbuijk K, van der Wall E, van Diest P, Moelans C Cancers (Basel). 2022; 14(1).

PMID: 35008326 PMC: 8750428. DOI: 10.3390/cancers14010159.


Non-Invasive Biomarkers for Early Detection of Breast Cancer.

Li J, Guan X, Fan Z, Ching L, Li Y, Wang X Cancers (Basel). 2020; 12(10).

PMID: 32992445 PMC: 7601650. DOI: 10.3390/cancers12102767.


Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.

Chen Z, Li Z, Li H, Jiang Y Onco Targets Ther. 2019; 12:6797-6811.

PMID: 31686838 PMC: 6709037. DOI: 10.2147/OTT.S215628.


References
1.
Mannello F, Medda V, Smaniotto A, Tonti G . Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer. Expert Rev Endocrinol Metab. 2019; 4(5):493-505. DOI: 10.1586/eem.09.28. View

2.
Mannello F, Medda V, Tonti G . Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Rev Proteomics. 2009; 6(1):43-60. DOI: 10.1586/14789450.6.1.43. View

3.
Kind T, Wohlgemuth G, Lee D, Lu Y, Palazoglu M, Shahbaz S . FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009; 81(24):10038-48. PMC: 2805091. DOI: 10.1021/ac9019522. View

4.
PETRAKIS N, Lowenstein J, Wiencke J, Lee M, Wrensch M, King E . Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women. Cancer Epidemiol Biomarkers Prev. 1993; 2(6):573-9. View

5.
PETRAKIS N, Lee R, Miike R, DUPUY M, Morris M . Coloration of breast fluid related to concentration of cholesterol, cholesterol epoxides, estrogen, and lipid peroxides. Am J Clin Pathol. 1988; 89(1):117-20. DOI: 10.1093/ajcp/89.1.117. View